Pulmonary hypertensive crisis

A pulmonary hypertensive crisis is a sudden episode of physical stress that causes a sharp, dangerous increase in blood pressure in the lungs of a person with pulmonary hypertension (PH). This can result in increased pressure in the right ventricle and a drop in the amount of blood the heart can pump throughout the body.

Due to these episodes, patients are at higher risk of experiencing low oxygen levels, or hypoxia. This can worsen levels of oxygen in the tissues, contribute to even more pressure on the lungs and heart, and even cause death. Treatment involves routine emergency medications and supportive medical practices.

Pulmonary hypertensive crises are closely related to PH, particularly in children.

Symptoms and diagnosis

During right ventricular overload in a PH crisis, enlargement of the right ventricle shifts the interventricular septum (the wall dividing the heart chambers) toward the left ventricle, compressing it and preventing it from filling.

Cardiac output becomes compromised, which can be identified by pulmonary hypertensive crisis symptoms such as:

  • an irregular heartbeat
  • a racing pulse
  • passing out or dizziness
  • progressive shortness of breath, particularly during exercise or activity
  • difficulty breathing at rest

Due to the severity of pulmonary hypertensive crises, patients who are more likely to have them and/or their caregivers need to be particularly aware of the symptoms and early signs.

Who is at risk?

Persistent PH of the newborn (PPHN) is a rare and rapidly developing type of PH that affects babies’ blood vessels at birth. As newborns’ pulmonary vascular beds – the networks of blood vessels in their lungs – react to stimuli quickly and severely, infants with PPHN are prone to drastic swings in blood pressure.

In newborns, pulmonary vascular resistance, or how hard the right ventricle of the heart has to work to pump blood, should drop at birth once they start to breathe. However, in most children with PPHN, pulmonary hypertensive crises can occur when this fall does not happen.

Patients who undergo surgery to treat PH are particularly at risk of postoperative PH crises. A hypertensive crisis is an acute, life-threatening complication most commonly triggered during cardiac catheterization, sedation, or surgical procedures.

Identifying, monitoring, and preventing crises

Preoperative evaluation, including invasive hemodynamic assessments, is one way to detect the risk of crises.

The International Society for Heart and Lung Transplantation (ISHLT) guidelines highlight three warning signs that let care teams spot a pulmonary hypertensive crisis before it develops into or worsens heart failure:

  • A sudden drop in central venous oxygen (ScvO2): This shows the body’s response to a heart that cannot pump freshly oxygenated blood around the body. Tissues around the body take nearly all the oxygen from the slow-moving bloodstream instead. Testing blood from a central line will show this sharp decrease, indicating that overall blood flow has declined sharply.
  • A quick fall in blood pressure: Because the right ventricle cannot force blood through the lungs over to the heart’s left side, this side of the heart cannot fill with blood. When this does not happen, blood pressure falls throughout the body, which can deprive vital organs and the heart muscle of necessary oxygen.
  • Acute right ventricular dilation on bedside echocardiography: An ultrasound at the bedside lets doctors watch and assess the heart on a screen. As pressure in the lungs spikes, the right ventricle balloons outward and flattens the wall that separates the heart’s chambers, known as the interventricular septum, under the strain.

A set protocol allows surgeons to limit the risk of pumlonary hypertensive crises during surgery. This includes:

  • An expert care team should be assembled, including a PH specialist, an anesthesiologist who specializes in heart conditions, and the surgeon performing the procedure.
  • The care team should assess the heart’s blood flow and ability to withstand strain within two weeks of surgery. This assessment may include an echocardiogram, a walking test, and the insertion of a catheter into the right side of the heart.
  • Medications may need to be adjusted before surgery. For example, dosages of blood pressure medications and diuretics (water pills) may be changed to reduce resistance in the right ventricle and help it pump as effectively as possible during the procedure.
  • Long-term medications should be administered without interruption. If there’s a possibility that the person may be unable to swallow, the care team should arrange for intravenous (IV) or inhaled versions.
  • The care team should plan anesthesia, breathing support, and pain management to avoid potential crisis triggers. These may include low oxygen levels, high carbon dioxide levels, low body temperature, and severe pain.
  • Emergency support systems should be prepared for higher-risk procedures. These may include inhaled life-support treatments or extracorporeal membrane oxygenation (ECMO), which mechanically transfers oxygen into the blood.

Treatment and prognosis

While some forms of PH may be treated by addressing their underlying cause, there is no cure for pulmonary arterial hypertension (PAH). However, treatments can help manage PAH and ease the burden of its symptoms.

Pulmonary hypertensive crisis treatments are also available. A combination of routine emergency medications and medical practices designed to reduce pulmonary arterial pressure and support the right ventricle can help to normalize blood pressure in the lungs during a pulmonary hypertensive crisis.

The ISHLT recommends the following for care teams managing pulmonary hypertensive crisis symptoms:

  • Inhaled pulmonary vasodilators: Emergency medications such as inhaled nitric oxide or inhaled prostacyclins (e.g., iloprost or epoprostenol) are delivered directly to the lungs. They rapidly dilate the constricted blood vessels to reduce pulmonary arterial pressure without causing a sharp drop in blood pressure across the entire body.
  • Inotropic support: Medications such as dobutamine or milrinone are administered to increase the right ventricle’s pumping strength. This strengthens its contractions, allowing it to pump blood despite high lung pressures.
  • Vasopressors for coronary perfusion: Drugs such as norepinephrine or vasopressin increase blood pressure to help the right ventricular muscle receive enough blood flow and oxygen through the coronary arteries.
  • Supportive critical care practices: Routine bedside practices help eliminate physical crisis triggers. This includes providing oxygen to correct hypoxemia (an abnormally low level of oxygen in the arterial blood), adjusting ventilator settings to clear carbon dioxide, correcting blood acid levels, and carefully limiting IV fluids to avoid overstretching and overwhelming the right ventricle.
  • Mechanical circulatory support (ECMO): If drug therapies fail to control pulmonary blood pressure, veno-arterial ECMO serves as a heart-lung bypass machine. It draws blood directly from the body, oxygenates it, and pumps it back into the arteries, instantly relieving the right ventricle’s workload.

Around 15% to 50% of patients with PH who undergo emergency surgery die within 30 days of the procedure, usually due to complications that involve right ventricular failure, according to research.

Rapid detection and intervention are central to preventing further consequences and improving survival.


Pulmonary Hypertension News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

FAQs about pulmonary hypertensive crisis